IBRX
IMMUNITYBIO (IBRX)
NASDAQ
$10.35+$1.07 (+11.48%)
Price as of Oct 02, 2026 6:02 PM EDT
  • $9.8B
    Market Cap
  • 271.20%
    1-Year Change
  • Biotechnology
    Industry
IBRX
vs History
vs S&P 500
General Statistics
Latest Close
$9.28
Change
-$0.16 (-1.69%)
Open
$9.28
High
$9.40
Low
$9.07
Previous Close
$9.44
Volume
12,313,714
30-Day Average Volume
11,237,012
1-Week Change
7.41%
1-Month Change
17.92%
1-Year Change
271.20%
3-Year Change
449.11%
5-Year Change
-7.29%
Fundamentals
Shares Outstanding
1.1B
Total Assets
$628.5M
Market Cap
$9.8B
Enterprise Value
$10.9B
Period:
QTR
TTM
FY
Revenue
$50.7M
Net Income
-$230.4M
Free Cash Flow
-$70.0M
EBIT
-$213.2M
EBITDA
-$208.8M
Net Working Capital
$362.3M
EPS
-$0.22
Enterprise Value/EBITDA
-52
Enterprise Value/Revenue
216
P/B
-9
P/E
-42
PEG
-1
Price/Free Cash Flow
-140
Price/Operating Cash Flow
-148
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue